Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype

被引:99
作者
Creery, WD
DiazMitoma, F
Filion, L
Kumar, A
机构
[1] CHILDRENS HOSP EASTERN ONTARIO,RES INST,OTTAWA,ON K1H 8L1,CANADA
[2] UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA,ON,CANADA
关键词
cytokine; B7-1; B7-2; monocyte; B cell;
D O I
10.1002/eji.1830260614
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The co-stimulatory molecules B7-1/B7-2 expressed on the surface of antigen-presenting cells have been suggested to influence the development of T helper 1 (Th1)-versus Th2-immune responses. These studies were conducted to elucidate the effect of immunoregulatory cytokines which influence the development of Th1/Th2 immune responses on the expression of the B7 isoforms B7-1 and B7-2 on resting and activated human monocytes and B cells. Interleukin (IL)-4 and IL-10, which induce the development of Th2 immune responses, down-regulated B7-2 and moderately up-regulated B7-1 expression on resting CD14(+) monocytes in peripheral blood mononuclear cells. Interferon-gamma (IFN-gamma), which induces the development of Th1 immune responses, enhanced the expression of both B7-1 and B7-2 isoforms. Tumor necrosis factor (TNF)-alpha, which elicits both Th1- and Th2 characteristics depending on experimental conditions, down-regulated B7-2 but did not alter B7-1 expression. The effect of TNF-alpha and B7-2 expression is not mediated through endogenously produced IL-10, as addition of anti-IL10 antibodies did not restore B7-2 expression. None of the other cytokines tested, including IL-1 alpha, IL-1 beta, IL-2, IL-5, IL-6, IL-12, granulocyte/macrophage colony-stimulating factor (GM-CSF), and transforming growth factor (TGF)-alpha, modulated the expression of B7 isoforms on resting monocytes. Lipoolysaccharide stimulation of monocytes down-regulated B7-2 and up-regulated B7-1 expression in a manner similar to IL-10. The expression of B7-1 and B7-2 on purified B cells were not altered by any of the cytokines tested, including IL-1 alpha, IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IFN-gamma, TNF-alpha, TGF-alpha and GM-CSF. Taken together, our results suggest that the cytokines which induce Th1/Th2 immune responses exert differential effects on B7 isoform expression on resting monocytes but have no effect on resting or activated B cells.
引用
收藏
页码:1273 / 1277
页数:5
相关论文
共 37 条
[1]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[2]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II(+)B7-1(+) TUMOR-CELLS ARE POTENT VACCINES FOR STIMULATING TUMOR REJECTION IN TUMOR-BEARING MICE [J].
BASKAR, S ;
GLIMCHER, L ;
NABAVI, N ;
JONES, RT ;
OSTRANDROSENBERG, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :619-629
[3]  
BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059
[4]   THE 2-SIGNAL MODEL OF LYMPHOCYTE-ACTIVATION 21 YEARS LATER [J].
BRETSCHER, P .
IMMUNOLOGY TODAY, 1992, 13 (02) :74-76
[5]   INTERLEUKIN-10 DIFFERENTIALLY REGULATES B7-1 (CD80) AND B7-2 (CD86) EXPRESSION ON HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS [J].
BUELENS, C ;
WILLEMS, F ;
DELVAUX, A ;
PIERARD, G ;
DELVILLE, JP ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2668-2672
[6]   B7-1 EXPRESSION OF LANGERHANS CELLS IS UP-REGULATED BY PROINFLAMMATORY CYTOKINES, AND IS DOWN-REGULATED BY INTERFERON-GAMMA OR BY INTERLEUKIN-10 [J].
CHANG, CH ;
FURUE, M ;
TAMAKI, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) :394-398
[7]  
CORRY DB, 1994, J IMMUNOL, V153, P4142
[8]   DYSREGULATED PRODUCTION OF INTERLEUKIN-10 (IL-10) AND IL-12 BY PERIPHERAL-BLOOD LYMPHOCYTES FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS IS ASSOCIATED WITH ALTERED PROLIFERATIVE RESPONSES TO RECALL ANTIGENS [J].
DAFTARIAN, MP ;
DIAZMITOMA, F ;
CREERY, WD ;
CAMERON, W ;
KUMAR, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (06) :712-718
[9]  
DESAI BB, 1992, J IMMUNOL, V148, P3125
[10]  
DING L, 1993, J IMMUNOL, V151, P1224